1. Home
  2. SAR vs IMRX Comparison

SAR vs IMRX Comparison

Compare SAR & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Saratoga Investment Corp New

SAR

Saratoga Investment Corp New

N/A

Current Price

$17.76

Market Cap

362.9M

Sector

Finance

ML Signal

N/A

Logo Immuneering Corporation

IMRX

Immuneering Corporation

N/A

Current Price

$4.46

Market Cap

313.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SAR
IMRX
Founded
2007
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
362.9M
313.8M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
SAR
IMRX
Price
$17.76
$4.46
Analyst Decision
Hold
Strong Buy
Analyst Count
4
5
Target Price
$23.75
$17.20
AVG Volume (30 Days)
132.9K
645.2K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
14.34%
N/A
EPS Growth
14.36
37.75
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.08
$3.86
52 Week High
$25.15
$9.65

Technical Indicators

Market Signals
Indicator
SAR
IMRX
Relative Strength Index (RSI) 34.52 44.32
Support Level N/A $4.49
Resistance Level $23.77 $5.32
Average True Range (ATR) 0.33 0.19
MACD 0.04 -0.04
Stochastic Oscillator 15.82 35.84

Price Performance

Historical Comparison
SAR
IMRX

About SAR Saratoga Investment Corp New

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: